You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

xelox

Showing 1 - 25 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Gastrointestinal Diseases, Stomach Cancer Trial (Anlotinib HCl capsule, Penpulimab Injection, XELOX)

Not yet recruiting
  • Carcinoma
  • +6 more
  • Anlotinib hydrochloride capsule
  • +2 more
  • (no location specified)
Aug 8, 2022

HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Locally Advanced Resectable Gastric Cancer
  • (no location specified)
Sep 3, 2023

Cancer of Stomach, Adenocarcinoma Trial in Hong Kong (5-FU, Leucovorin, Oxaliplatin, Docetaxel, XELOX)

Recruiting
  • Cancer of Stomach, Adenocarcinoma
  • 5-FU, Leucovorin, Oxaliplatin, Docetaxel
  • XELOX
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Mar 21, 2022

Advanced Rectal Cancer Trial in Guangzhou (XELOX, Capecitabine monotherapy, Radiation)

Not yet recruiting
  • Advanced Rectal Cancer
  • XELOX
  • +2 more
  • Guangzhou, Guangdong, China
    Zhenhai Lu
Oct 25, 2022

Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • (no location specified)
Nov 1, 2023

Rectal Cancer Trial in Chengdu (XELOX)

Completed
  • Rectal Cancer
  • XELOX
  • Chengdu, Sichuan, China
    Guoxue Road 37#,West China Hospital
Apr 28, 2022

Metastatic Colorectal Cancer, pMMR, MSS Trial in France (Atezolizumab, Therasphere, XELOX)

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Amiens, France
  • +18 more
Mar 23, 2022

HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Colorectal Cancer
  • HER2-positive Biliary Tract Cancer
  • Beijing, State*, China
    Peking University cancer hospital & institution
Aug 2, 2023

Rectal Tumors, Drug Therapy, Radiation Trial in Shenyang (FOLFOXIRI, Short-Course Radiation Therapy(5Gy*5), XELOX)

Recruiting
  • Rectal Neoplasms
  • +2 more
  • Shenyang, China
    China Medical University
Apr 13, 2021

Rectal Tumors Trial (procedure, drug, diagnostic test)

Not yet recruiting
  • Rectal Neoplasms
  • Arterial chemoembolization
  • +4 more
  • (no location specified)
Jun 26, 2022

MSI-H, PD-1 Immunotherapy, Gastric Cancer Trial in Shanghai (SOX, XELOX, Observation)

Not yet recruiting
  • MSI-H
  • +3 more
  • Shanghai, China
    Dazhi Xu
Jul 20, 2022

Rectal Cancer Trial in Stanford (FOLFOXIRI, FOLFOX regimen, XELOX)

Recruiting
  • Rectal Cancer
  • Stanford, California
    Stanford University
Jan 13, 2022

Gastric or Gastroesophageal Junction Adenocarcinoma, AFP Trial in Shenyang (Anti-PD-1 antibody, XELOX)

Recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • AFP
  • Anti-PD-1 antibody
  • XELOX
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Apr 13, 2021

Solid Tumor Trial in Singapore (CURATE.AI, Capecitabine, XELOX)

Recruiting
  • Solid Tumor
  • CURATE.AI
  • +4 more
  • Singapore, Singapore
  • +1 more
Dec 14, 2021

Rectal Cancer Trial in Beijing (combination product, drug, procedure)

Recruiting
  • Rectal Cancer
  • Concurrent Chemoradiotherapy
  • +3 more
  • Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Jan 23, 2022

Gastric Cancer Trial in Worldwide (AZD2936, MEDI5752, FOLFOX)

Recruiting
  • Gastric Cancer
  • Beijing, China
  • +25 more
Jan 18, 2023

Stomach Tumors Trial in Milan (RAMUCIRUMAB, Paclitaxel, FOLFOX 4)

Recruiting
  • Stomach Neoplasms
  • Milan, Italy
    Maria Di Bartolomeo
Sep 3, 2021

Colo-rectal Cancer Trial in Milano (XELOX, Radiotherapy)

Unknown status
  • Colo-rectal Cancer
  • XELOX
  • Radiotherapy
  • Milano, Italy
    ASST GOM Niguarda
Sep 8, 2020

Gastric Cancer Trial in Seoul (XELOX, XELODA)

Withdrawn
  • Gastric Cancer
  • Seoul, Korea, Republic of
    Samsung medical Center
Dec 26, 2019

Metastatic Colon Cancer, Surgery Trial in Shanghai (resection of primary tumor, XELOX, mFOLFOX6)

Recruiting
  • Metastatic Colon Cancer
  • Surgery
  • resection of primary tumor
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 1, 2020

Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)

Active, not recruiting
Has Results
  • Gastric Cancer
  • +2 more
  • BMS-986213
  • +4 more
  • Clovis, California
  • +77 more
Jan 9, 2023

Esophageal Cancer, Tumors, Esophageal Trial in Atlanta, Nashville (RAD001, XELOX, Carboplatin)

Completed
  • Esophageal Cancer
  • Neoplasms, Esophageal
  • Atlanta, Georgia
  • +2 more
Mar 14, 2019

Rectal Cancer Trial in Guangzhou (drug, other, procedure)

Recruiting
  • Rectal Cancer
  • Guangzhou, Guangdong, China
  • +1 more
Jan 20, 2019

Colorectal Tumors, Chemo Trial in Harbin (XELIRI, XELOX)

Unknown status
  • Colorectal Neoplasms
  • Chemotherapy
  • Harbin, Heilongjiang, China
    Harbin Medical University
Apr 29, 2018

Gastric Carcinoma Trial (Apatinib, XELOX)

Not yet recruiting
  • Gastric Carcinoma
  • (no location specified)
Nov 22, 2017